Hyperbaric Oxygen (HBOT) is another unnecessary therapy marketed for Lyme disease.
HBOT has not, however, been proven to be the kind of universal treatment it has been touted to be on some Internet sites. FDA is concerned that some claims made by treatment centers using HBOT may give consumers a wrong impression that could ultimately endanger their health.
A 2015 review of 30 unproven or disproven therapies advertised for Lyme disease noted “No study of [HBOT] in humans with Lyme disease has ever been published.” Why use hyperbaric oxygen when Lyme disease is a treatable infection?
HBOT is not cleared as safe and effective for Lyme disease by the FDA, and HBOT is not approved for Lyme disease by the Undersea and Hyperbaric Medical Society (UHMS).
Johns Hopkins lists a series of side effects that can occur from HBOT inside a hyperbaric chamber. Though most side effects are generally mild, HBOT is not risk-free.
One hyperbaric oxygen peddler was disciplined for the unauthorized practice of medicine.